Key facts
- This page summarizes John Ciccio's Form 5 filing for OS Therapies Inc (OSTX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Feb 2025, 16:22.
John Ciccio - 31 Dec 2024 Form 5 Insider Report for OS Therapies Inc (OSTX)
- Reporting relationship
- Director
- Issuer ticker
- OSTX
- Reported as of
- 31 Dec 2024
- Net transaction value
- $0
- SEC form
- 5
- Accepted by SEC
- 14 Feb 2025, 16:22:09 UTC
- Prior SEC filing
- 06 Aug 2024
- Next SEC filing
- 19 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Ciccio
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Ciccio filed Form 5 for OS Therapies Inc (OSTX) on 14 Feb 2025.
Change
- Previous filing in this sequence was filed on 06 Aug 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OSTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 435,835
- Date
- 31 Dec 2024
- Ownership
- Mill River Partners LLC
- Footnotes
- F1
OSTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 20,000
- Date
- 31 Dec 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OSTX
transaction
Derivative
Non-qualified stock options (right to buy)
Award
- Transaction value
- $0
- Shares
- +40,000
- Change %
- Price
- $0.000000
- Shares after
- 40,000
- Date
- 05 Dec 2024
- Ownership
- Direct
- Underlying class
- Common stock, par value $0.001 per share
- Underlying amount
- 40,000
- Exercise price
- $1.86
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
John Ciccio serves on the board of managers of MRP and shares voting and investment power with respect to these shares.
Footnote F2
On December 5, 2024, the reporting person was granted non-qualified stock options to purchase 40,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and subject to certain vesting conditions.